Index/Topics/FTD Disease-Modifying Treatments

FTD Disease-Modifying Treatments

The primary topic is about the absence of regulator-approved disease-modifying treatments for frontotemporal dementia (FTD), despite the existence of investigational biologics and conventional drugs aimed at genetically defined FTD subtypes.